This study aimed to ascertain pathologic findings of surgical follow-up excision (FUE) on
patients who had radiologic finding of calcifications and lobular neoplasia (LN) on core …

The appropriate follow-up and treatment for patients with a core biopsy diagnosis of lobular
neoplasia (atypical lobular hyperplasia or lobular carcinoma in situ) remains controversial …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) diagnosed in core
needle biopsy (CNB) are generally regarded as risk indicators for developing invasive …

The purpose of this study was to determine whether there is a criterion that can be utilized to
determine if excisional biopsy is indicated following the diagnosis of lobular neoplasia (LN) …

A core biopsy diagnosis of atypical ductal epithelial hyperplasia is upstaged on follow-up
excisional biopsy (FUEB) to in situ or invasive carcinoma in about 20% of cases, thus …

The management of a core biopsy diagnosis of lobular neoplasia is controversial. Detailed
radiological–pathological review of 47 patients with cores showing classical lobular …

PURPOSE: To review outcomes of lesions diagnosed at core-needle breast biopsy as
atypical lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS). MATERIALS AND …

Core needle biopsy is the preferred technique for evaluating breast masses and abnormal
mammographic findings. The frequency of detection of noninvasive lobular lesions by core …

Background Management recommendations for lobular neoplasia (LN) including lobular
carcinoma-in-situ (LCIS) and atypical lobular hyperplasia (ALH) diagnosed in core biopsies …

Abstract BACKGROUND. Lobular neoplasia (LN), encompassing atypical lobular
hyperplasia (ALH) and lobular carcinoma in situ (LCIS), is often an incidental finding on core …